Showing results (21-30 of 156) with videos related to
Sort By:
Pageof 16
Alzheimer'S & Dementia (New York, N. Y.)|December 1, 2025
Relationship between efficacy and preferential targeting of soluble Aβ aggregatesJohanne M Kaplan, Ebrima Gibbs, Juliane A Coutts, et al.Iscience|June 2, 2020
Purification and Structural Characterization of Aggregation-Prone Human TDP-43 Involved in Neurodegenerative DiseasesGareth S A Wright, Tatiana F Watanabe, Kangsa Amporndanai, et al.Proceedings of the National Academy of Sciences of the United States of America|September 13, 2007
Generalization of distance to higher dimensional objectsSteven S PlotkinCurrent Drug Metabolism|April 8, 2003
Induced adaptive resistance to oxidative stress in the CNS: a discussion on possible mechanisms and their therapeutic potentialAmy Bishop, Neil R CashmanNature Reviews. Drug Discovery|October 2, 2004
Prion diseases--close to effective therapy?Neil R Cashman, Byron CaugheyScientific Reports|July 10, 2019
A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer's DiseaseEbrima Gibbs, Judith M Silverman, Beibei Zhao, et al.Frontiers in Neuroscience|November 22, 2016
Susceptibility of Mutant SOD1 to Form a Destabilized Monomer Predicts Cellular Aggregation and Toxicity but Not In vitro Aggregation PropensityLuke McAlary, J Andrew Aquilina, Justin J YerburyThe Journal of Biological Chemistry|August 6, 2002
Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like formWen-Quan Zou, Neil R CashmanExpert Opinion on Biological Therapy|February 16, 2005
Progress in prion vaccines and immunotherapiesJennifer K Griffin, Neil R CashmanPageof 16